Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
Advisory bodiesCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMusculoskeletal and skin diseasesOrgan and tissue donation and transplantationResearch administration and fundingResearch and development
National Commission on Scleroderma and Fibrotic Diseases Act of 2019
USA116th CongressHR-3446| House
| Updated: 6/25/2019
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
Advisory bodiesCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMusculoskeletal and skin diseasesOrgan and tissue donation and transplantationResearch administration and fundingResearch and development